Causes of Nephrogenic Diabetes Insipidus
Nephrogenic diabetes insipidus results from either inherited genetic mutations affecting the vasopressin signaling pathway or acquired conditions that impair the kidney's ability to respond to antidiuretic hormone.
Congenital (Hereditary) Causes
Approximately 90% of congenital NDI cases are X-linked, caused by pathogenic variants in the AVPR2 gene (chromosome Xq28), which encodes the vasopressin V2 receptor, predominantly affecting males 1, 2. These mutations lead to insensitivity of the distal nephron to arginine vasopressin, preventing the kidney from concentrating urine 1.
The remaining 10% of hereditary cases result from mutations in the AQP2 gene (chromosome 12q13.12), which encodes the aquaporin-2 water channel 1, 2. These autosomal forms can be inherited as:
- Autosomal-recessive NDI (OMIM #222000), affecting males and females equally 1
- Autosomal-dominant NDI (OMIM #125800), which may be underdiagnosed as patients can partially compensate and show milder symptoms 1
Molecular Pathophysiology
Most AVPR2 pathogenic variants produce fully translated proteins that are misfolded and retained within the endoplasmic reticulum, preventing proper trafficking to the cell membrane 1. Similarly, all pathogenic variants related to autosomal-recessive NDI lead to misfolded AQP2 proteins that cannot reach the apical membrane 1.
Acquired (Secondary) Causes
Secondary forms of NDI are more frequent than congenital forms and result from conditions or exposures that impair renal concentrating ability 1.
Drug-Induced NDI
Lithium is the most common cause of drug-induced NDI, affecting approximately 10% of patients on long-term treatment (≥15 years) 3. In the WHO adverse effect database, lithium accounted for 159 of 359 reports of drug-induced diabetes insipidus 3.
Other medications causing NDI include:
- Foscarnet (15 reports in WHO database) 3
- Clozapine (10 reports) 3
- Antimicrobials and cytostatics, particularly in critically ill patients receiving multiple drugs 3
- Demeclocycline 4
Drug-induced NDI is always of the nephrogenic type, representing renal unresponsiveness to antidiuretic hormone 3. The condition may be only partly reversible upon lithium discontinuation in long-term users 3.
Electrolyte Disturbances
Hypercalcemia and hypokalemia are well-established causes of acquired NDI 5, 6, 4. These electrolyte abnormalities disturb the aquaporin-2 shuttle mechanism, which is the underlying molecular basis of acquired NDI 4.
Chronic Kidney Disease
Other inherited kidney diseases that affect urinary concentrating ability can present with secondary NDI 1. Chronic pyelonephritis and obstructive uropathy are recognized causes 5, 6.
Untreated congenital NDI itself can lead to chronic kidney disease, severe bilateral hydronephrosis, hypertension, and severe bladder dysfunction over time 7. Approximately 50% of adults with NDI develop chronic kidney disease stage ≥2 8.
Infectious Causes
Syphilis has been documented as a rare cause of acquired NDI 6. In one reported case, renal biopsy showed abundant plasmacytic and lymphocytic infiltration of the interstitium with low and flat tubular epithelial cells, indicating renal tubular injury, with silver staining revealing Treponema pallidum organisms 6. The NDI resolved after appropriate antibiotic treatment 6.
Clinical Pitfalls and Diagnostic Considerations
The manifestations of acquired NDI are diverse, and the condition can result from multiple simultaneous factors in critically ill patients 6, 3.
Lithium-induced NDI is a serious adverse effect because of the risk of developing dehydration and aggravation of drug intoxications 3. Close monitoring with 12-hour trough lithium levels of 0.4 to 0.6 mmol/L is recommended, along with yearly measurement of urinary volume to detect early development of NDI 3.
Secondary NDI should be distinguished from congenital forms through comprehensive family history, pedigree analysis, and early genetic testing when hereditary disease is suspected 1, 8. The combination of inappropriately dilute urine (osmolality <200 mOsm/kg H2O) with high-normal or elevated serum sodium is pathognomonic for diabetes insipidus, but does not distinguish between central and nephrogenic causes 1, 8.
Identifying and correcting the underlying disorder or withdrawing the offending drug is the primary therapeutic approach for acquired NDI 4. However, prevention is critical, particularly for lithium-induced cases, as the condition may be only partially reversible after long-term exposure 3.